企業合併與收購之效益分析

Analysis on the Benefit of the Coherent Mergers and Acquisitions

林秀琦(Napassorn Pinitkitjawat)

Advisor ： 劉助

國立政治大學/商學院/國際經營管理英語碩士學位學程(IMBA)/碩士(2020年)

https://doi.org/10.6814/NCCU202000993

Abstracts

本論文以英文書寫，作者無提供中文摘要。

Keywords

合併與收購 ； 必治妥施貴寶 ； 賽爾基因收購案 ； 合併與收購的利益

Parallel abstracts

With the disruptive technology and the rapid change in the business environment, the current business environment results in a spike in the M&A activity. But is M&A beneficial to companies? Fundamental analysis on the actual financial performance for pre- and post-M&A of the sample M&A case, Bristol Myers Squibb – Celgene Acquisition is conducted to help determine if this business methodology truly bring about benefits to the companies over the study period.

Parallel keywords

Mergers and Acquisitions ； Bristol Myers Squibb ； Celgene Acquisition ； Benefit of Mergers and Acquisitions

References

Arık, E., & Kutan, A. M. (2015). Do Mergers and Acquisitions Create Wealth Effects? Evidence from Twenty Emerging Markets. Eastern European Economics, 53(6), 529–550. https://doi.org/10.1080/00128775.2015.1099445

Bansal, De Backer, and Ranade. (2018, October 10). What’s behind the pharmaceutical sector’s M&A push. Retrieved from https://www.mckinsey.com/business-functions/strategy-and-corporate-finance/our-insights/whats-behind-the-pharmaceutical-sectors-m-and-a-push

BRISTOL MYERS SQUIBB drug patent status, international patents. (2020, June 15). Retrieved from https://www.drugpatentwatch.com/p/applicant/Bristol%20Myers%20Squibb

Brown, and Elmhirst. (2018, October 3). Few biopharma buyouts in quiet third quarter. Retrieved from https://www.evaluate.com/vantage/articles/data-insights/ma/few-biopharma-buyouts-quiet-third-quarter

Celgene: A Winner in Biopharma. (2015, December 10). Retrieved from https://digital.hbs.edu/platform-rctom/submission/celgene-a-winner-in-biopharma/